📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma. (2021)

First Author: Graham CE

Attributed to: Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-021-01324-z

PubMed Identifier: 34145373

Publication URI: http://europepmc.org/abstract/MED/34145373

Type: Journal Article/Review

Volume: 35

Parent Publication: Leukemia

Issue: 12

ISSN: 0887-6924